User profiles for Giacomo De Luca

Giacomo Davide De Luca

Professor of Economics
Verified email at unibz.it
Cited by 1211

Arrhythmias in myocarditis: state of the art

G Peretto, S Sala, S Rizzo, G De Luca, C Campochiaro… - Heart rhythm, 2019 - Elsevier
Many kinds of arrhythmias may occur in patients with myocarditis at any stage of the disease.
However, compared to the other clinical presentations, arrhythmic myocarditis has been …

[HTML][HTML] Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort …

G Cavalli, G De Luca, C Campochiaro… - The Lancet …, 2020 - thelancet.com
Background Mortality of patients with coronavirus disease 2019 (COVID-19), acute respiratory
distress syndrome (ARDS), and systemic inflammation is high. In areas of pandemic …

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

…, E Della-Torre, G Cavalli, G De Luca… - European journal of …, 2020 - Elsevier
Background Tocilizumab (TCZ), a humanized monoclonal antibody targeting the interleukin-6
(IL-6) receptor, has been proposed for the treatment of COVID-19 patients; however, …

[HTML][HTML] Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors

…, A Mastrangelo, C Muccini, G Monti, G De Luca… - Clinical Microbiology …, 2021 - Elsevier
Objectives The aim of our study was to describe the incidence and predictive factors of
secondary infections in patients with coronavirus disease 2019 (COVID-19). Methods This was a …

Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series

…, A Tomelleri, R Ferrara, C Lazzari, G De Luca… - European Journal of …, 2021 - Elsevier
Objective Research is moving towards a more personalized management of immune-related
adverse events (irAEs) due to immune checkpoint inhibitors (ICI). Our objective was to …

B cells in systemic sclerosis: a possible target for therapy

S Bosello, G De Luca, B Tolusso, G Lama… - Autoimmunity …, 2011 - Elsevier
Systemic sclerosis (SSc) is an autoimmune disease characterized by excessive extracellular
matrix (ECM) deposition in the skin and other visceral organs and it is associated with …

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study

…, C Campochiaro, G Cavalli, G De Luca… - Annals of the …, 2020 - ard.bmj.com
Objectives To assess the safety and efficacy of interleukin (IL)−6 blockade with sarilumab in
patients with severe COVID-19 pneumonia and systemic hyperinflammation. Methods We …

[HTML][HTML] GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study

G De Luca, G Cavalli, C Campochiaro… - The Lancet …, 2020 - thelancet.com
Background Mortality in patients with COVID-19 pneumonia and systemic
hyperinflammation is high. We aimed to examine whether mavrilimumab, an anti-granulocyte–macrophage …

[HTML][HTML] Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study

…, C Campochiaro, E Della-Torre, G De Luca… - The Lancet …, 2021 - thelancet.com
Background Patients with severe COVID-19 develop a life-threatening hyperinflammatory
response to the virus. Interleukin (IL)-1 or IL-6 inhibitors have been used to treat this patient …

Ethnic favoritism: An axiom of politics?

G De Luca, R Hodler, PA Raschky… - Journal of Development …, 2018 - Elsevier
We study ethnic favoritism in a global sample and rely on nighttime light intensity to capture a
broad range of preferential policies targeted towards the political leaders' ethnic homelands…